- Companies
- ICU Girisim Sermayesi
ICU Girisim Sermayesi Valuation Multiples
ICU Girisim Sermayesi is valued at $15M as of September 2026. In the last fiscal year, ICU Girisim Sermayesi EBITDA was ($4M).
ICU Girisim Sermayesi Overview
About ICU Girisim Sermayesi
ICU Girisim Sermayesi Yatirim Ortakligi AS is a Turkey based investment banking company. It operates as a venture capital company. The company invests in portfolio of companies which includes OEP RHEA Turkey Tech, Seta Medical, Netsafe Information System, and RML Lines.
Founded
1996
HQ
Employees
6
Website
Sectors
Financials (Last FY)
EV
$15M
Valuation Multiples
Start free trialICU Girisim Sermayesi Financials
ICU Girisim Sermayesi reported last fiscal year revenue of - and negative EBITDA of ($4M).
In the same fiscal year, ICU Girisim Sermayesi generated - in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
ICU Girisim Sermayesi P&L
In the most recent fiscal year, ICU Girisim Sermayesi reported revenue of - and EBITDA of ($4M).
ICU Girisim Sermayesi is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.
Financial data powered by Morningstar, Inc.
ICU Girisim Sermayesi Stock Performance
ICU Girisim Sermayesi has current market cap of $15M, and enterprise value of $15M.
ICU Girisim Sermayesi's stock price is $0.04.
ICU Girisim Sermayesi has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15M | $15M | -9.9% | - | - | - | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialICU Girisim Sermayesi Valuation Multiples
ICU Girisim Sermayesi trades at (3.5x) EV/EBITDA.
ICU Girisim Sermayesi Financial Valuation Multiples
As of September 23, 2026, ICU Girisim Sermayesi has market cap of $15M and EV of $15M.
ICU Girisim Sermayesi has a P/E ratio of (3.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ICU Girisim Sermayesi Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


ICU Girisim Sermayesi Operational KPIs
ICU Girisim Sermayesi's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.7M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
ICU Girisim Sermayesi Competitors
ICU Girisim Sermayesi competitors include BTC Health, Xer Tech Holding, Eurocastle Investment, AG Ventures, Fuel Ventures, Pardus Girişim, EMV Capital, Coinsilium Group, Capital Point and Tern.
Most ICU Girisim Sermayesi public comparables operate across PE & VC.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $68K | ($414K) | 206.1x | - | (33.7x) | - | |||
| $15K | ($178K) | 826.9x | - | (70.8x) | - | |||
| $271K | - | 58.0x | - | - | - | |||
| $11M | $1M | 1.2x | - | 11.7x | - | |||
| $516K | - | 32.7x | - | - | - | |||
| $1M | $986K | 11.2x | - | 15.1x | - | |||
| $4M | ($325K) | 4.7x | 4.3x | (55.0x) | (2343.7x) | |||
| $8K | ($7M) | 1902.1x | - | (2.0x) | - | |||
This data is available for Pro users. Sign up to see all ICU Girisim Sermayesi competitors and their valuation data. Start Free Trial | ||||||||
Investments by ICU Girisim Sermayesi
ICU Girisim Sermayesi has invested in 5 companies to date.
Latest investment by ICU Girisim Sermayesi was on March 1st 2025. ICU Girisim Sermayesi invested in Atabeg in their Seed round.
Latest Investments by ICU Girisim Sermayesi
| Description | Atabeg Danışmanlık ve Eğitim Teknolojileri A.Ş. is a Turkish education technology company. It runs the Atabeg platform, which prepares and delivers mobile and web training programmes for Turkish public sector employees and candidates, supporting their professional development and their preparation for the national public personnel selection examination known as KPSS and for promotion, title and status change examinations. The business earns revenue from course and subscription fees paid by candidates and public employees. The company was incorporated in March 2025 and decided in April 2025 to open a branch in the Aydın Adnan Menderes University Technology Development Zone in order to carry out its research and development and commercial activities from a technopark base. ICU Girişim Sermayesi Yatırım Ortaklığı holds a 15 percent shareholding in the company. | MARS is a digital finance provider offering specialized card products and rewards programs for everyday transactions and business expenses. The platform supports virtual and physical cards with customizable limits, cashback incentives, and integration for expense tracking. Targeting consumers and SMEs in emerging markets, MARS operates from its Neo platform, emphasizing secure mobile-first banking accessible via iOS and Android apps across multiple countries. | ISM Medikal Yatırımlar Sanayi ve Ticaret A.Ş. is a Turkish manufacturer of medical consumables and personal protective equipment. It began trading on 16 June 2020 under the name Coenda Medikal Sanayi ve Ticaret A.Ş. with the purpose of manufacturing, investing in and selling medical products in Turkey and abroad, and it changed its shareholders and its name to ISM Medikal Yatırımlar on 26 October 2023. Its main activity is producing surgical gowns, coveralls, complete operating theatre sets, personal protective medical equipment, surgical masks, diagnostic kits and injections, and it operates a sterilisation unit that allows it to sterilise all types of product. Revenue comes from product sales to hospitals, distributors and institutional buyers. The company applied to the Turkish Ministry of Industry and Technology and obtained an investment incentive certificate for a complete new regional high-technology investment intended to bring its production across Turkey under one roof. | Laska Teknoloji A.Ş. is a Turkish research and development company that recycles end-of-life vehicle tyres. The company processes waste tyres in a way that eliminates their carbon emissions and environmental residues and returns the material to the economy, producing high value-added carbon black together with steel and an energy output. It earns revenue from the sale of recovered carbon black, recovered steel and energy to industrial customers. Carbon black recovered from tyres competes with virgin carbon black used in rubber, plastics and pigment applications, and the business sits in the circular economy and clean technology segment of the Turkish industrial market. ICU Girişim Sermayesi Yatırım Ortaklığı acquired a 7.5 percent shareholding in the company through a capital increase in 2021 and continues to hold the position. | |
| HQ Country | |||||
| HQ City | Aydın | İstanbul | - | - | |
| Deal Date | 1 Mar 2025 | 5 Dec 2024 | 28 Mar 2024 | 25 Jun 2021 | |
| Round | Seed | Seed | Undisclosed stage | Strategic investment | |
| Raised | undisclosed | $3M | undisclosed | undisclosed | |
| Investors | ICU Girisim Sermayesi | ICU Girisim Sermayesi; Arz Portfolio; StartupFon; Sina Afra; Kultura Capital Management | ICU Girisim Sermayesi | ICU Girisim Sermayesi | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all ICU Girisim Sermayesi investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ICU Girisim Sermayesi
| When was ICU Girisim Sermayesi founded? | ICU Girisim Sermayesi was founded in 1996. |
| Where is ICU Girisim Sermayesi headquartered? | ICU Girisim Sermayesi is headquartered in Turkey. |
| How many employees does ICU Girisim Sermayesi have? | As of today, ICU Girisim Sermayesi has over 6 employees. |
| Is ICU Girisim Sermayesi publicly listed? | Yes, ICU Girisim Sermayesi is a public company listed on Borsa Istanbul. |
| What is the stock symbol of ICU Girisim Sermayesi? | ICU Girisim Sermayesi trades under ICUGS ticker. |
| When did ICU Girisim Sermayesi go public? | ICU Girisim Sermayesi went public in 2000. |
| Who are competitors of ICU Girisim Sermayesi? | ICU Girisim Sermayesi main competitors include BTC Health, Xer Tech Holding, Eurocastle Investment, AG Ventures, Fuel Ventures, Pardus Girişim, EMV Capital, Coinsilium Group, Capital Point, Tern. |
| What is the current market cap of ICU Girisim Sermayesi? | ICU Girisim Sermayesi's current market cap is $15M. |
| Is ICU Girisim Sermayesi profitable? | No, ICU Girisim Sermayesi is not profitable. |
| How many companies ICU Girisim Sermayesi has acquired to date? | ICU Girisim Sermayesi hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies ICU Girisim Sermayesi has invested to date? | As of September 2026, ICU Girisim Sermayesi has invested in 5 companies. |
| What was the last ICU Girisim Sermayesi investment? | On 1st March 2025 ICU Girisim Sermayesi invested in Atabeg, participating in a Seed round. |
| In what companies ICU Girisim Sermayesi invested in? | ICU Girisim Sermayesi invested in MARS, SETA Tıbbi Cihazlar, Laska Teknoloji, ISM Medikal Yatırımlar, and Atabeg. |
See public comps similar to ICU Girisim Sermayesi
Lists including ICU Girisim Sermayesi
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




